Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Details about genomic landscapes of AML and endometrial cancer revealed

Details about genomic landscapes of AML and endometrial cancer revealed

Intermediate anti-tTG levels affects birth outcomes, new study reveals

Intermediate anti-tTG levels affects birth outcomes, new study reveals

Laparoscopic radical nephropathy effective for advanced renal masses

Laparoscopic radical nephropathy effective for advanced renal masses

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Research maps risk factors for transmission of animal brucellosis, BTB to humans

Research maps risk factors for transmission of animal brucellosis, BTB to humans

Data from MK-5172 Phase II study for treatment of HCV genotype 1 infection to be presented at EASL meeting

Data from MK-5172 Phase II study for treatment of HCV genotype 1 infection to be presented at EASL meeting

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Amgen agrees to $25M settlement after kickback allegations

Amgen agrees to $25M settlement after kickback allegations

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

First Edition: April 17, 2013

First Edition: April 17, 2013

Large numbers of ER visits go unreported in calculating hospital readmission rates

Large numbers of ER visits go unreported in calculating hospital readmission rates

VCU researchers shed light on biopsychosocial, spiritual effects of taking opioids for noncancer pain

VCU researchers shed light on biopsychosocial, spiritual effects of taking opioids for noncancer pain

New data on Merck’s VICTRELIS for chronic HCV to be presented at EASL annual meeting

New data on Merck’s VICTRELIS for chronic HCV to be presented at EASL annual meeting

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Study results show trends in surgical management of patients with kidney disease

Study results show trends in surgical management of patients with kidney disease

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Johns Hopkins undergraduates develop Cooling Cure to protect newborn from brain damage

Johns Hopkins undergraduates develop Cooling Cure to protect newborn from brain damage

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

MU researchers redefine key regulatory process in defective protein responsible for cystic fibrosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.